Zealand Pharma A/S
ZLDPF
$40.99
-$0.01-0.02%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 38.34% | -99.44% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 38.34% | -99.44% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 38.34% | -99.44% | |||
| SG&A Expenses | -52.13% | 77.93% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 21.12% | -29.84% | |||
| Operating Income | -19.27% | -105.70% | |||
| Income Before Tax | -10.29% | -104.66% | |||
| Income Tax Expenses | -172.68% | -92.81% | |||
| Earnings from Continuing Operations | 6.68% | -105.50% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.68% | -105.50% | |||
| EBIT | -19.27% | -105.70% | |||
| EBITDA | -20.62% | -105.60% | |||
| EPS Basic | 6.75% | -105.53% | |||
| Normalized Basic EPS | -19.28% | -104.90% | |||
| EPS Diluted | 6.75% | -105.61% | |||
| Normalized Diluted EPS | -19.28% | -104.97% | |||
| Average Basic Shares Outstanding | 0.08% | -0.60% | |||
| Average Diluted Shares Outstanding | 0.08% | -1.97% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||